Stock ANAB ANAPTYSBIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart AnaptysBio, Inc.

Equities

ANAB

US0327241065

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-21 pm EDT 		5-day change 1st Jan Change
23.95 USD -4.24% Intraday chart for AnaptysBio, Inc. -5.19% +11.81%
May. 09 AnaptysBio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 09 Anaptys Announces Positive Top-Line Gemini-2 Phase 3 Clinical Trial Results of imsidolimab (IL-36R) in Generalized Pustular Psoriasis CI
53638fa4500e.azZNmiki99IKUdJ2uBsisNJkT2gsZfJO9dYzUFBohrk.OX58ok8Qh-U5GKgv321x2YgMOCMBH7kMx59WBAYStuA7eXnQWmPaqGFkvQ~dcd8aa51a60c107ebb8c4ebf13d04cb6
  1. Stock Market
  2. Equities
  3. ANAB Stock
  4. Charts AnaptysBio, Inc.
  5. News Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW